Clinical Trial Update: Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in China [Phase 4]

View source ↗

Summary

Phase 4 post-marketing trial evaluating the immunogenicity and safety of an inactivated Enterovirus 71 vaccine in children aged 6-35 months in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• Inactivated Enterovirus 71 vaccine (Inactivated Enterovirus 71 vaccine)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Hand, Foot and Mouth Disease | Phase 4 | Status: COMPLETED